State Street Corp Alx Oncology Holdings Inc Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, State Street Corp holds 684,123 shares of ALXO stock, worth $752,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
684,123
Previous 671,376
1.9%
Holding current value
$752,535
Previous $1.22 Million
6.47%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALXO
# of Institutions
98Shares Held
39.7MCall Options Held
136KPut Options Held
28.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.7 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$4.06 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.63 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$2.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.75 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $44.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...